Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. (Q37621828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

review article

1 reference

title

Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sunil R Hingorani

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

14

Margaret Tempero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Philip A Philip

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Margaret Mooney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Deborah Jaffe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Gail Eckhardt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Malcolm Moore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Neal Meropol

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Leisha Emens

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Murray Korc

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Lee Ellis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jacqueline Benedetti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Mace Rothenberg

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Christopher Willett

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Andrew Lowy

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

James Abbruzzese

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Diane Simeone

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jordan Berlin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Joel Tepper

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

26 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

5660-5669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

11 February 2020

cites work

1 reference

12 December 2020

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

12 December 2020

Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design

1 reference

12 December 2020

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

1 reference

12 December 2020

K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster

1 reference

12 December 2020

Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.

1 reference

12 December 2020

An in vivo platform for translational drug development in pancreatic cancer

1 reference

12 December 2020

Design issues of randomized phase II trials and a proposal for phase II screening trials

1 reference

12 December 2020

Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation.

1 reference

12 December 2020

Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis

1 reference

12 December 2020

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

1 reference

12 December 2020

Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination.

1 reference

12 December 2020

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

1 reference

12 December 2020

Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines

1 reference

12 December 2020

Cancer-associated stromal fibroblasts promote pancreatic tumor progression

1 reference

12 December 2020

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials

1 reference

12 December 2020

Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts

1 reference

12 December 2020

Farnesyltransferase inhibitors as anticancer agents: current status.

1 reference

12 December 2020

Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment

1 reference

12 December 2020

Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation

1 reference

12 December 2020

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704

1 reference

12 December 2020

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition

1 reference

12 December 2020

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

1 reference

12 December 2020

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

1 reference

12 December 2020

Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia

1 reference

12 December 2020

Ras family signaling: therapeutic targeting

1 reference

12 December 2020

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

1 reference

12 December 2020

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

1 reference

12 December 2020

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer

1 reference

12 December 2020

Genetics and biology of pancreatic ductal adenocarcinoma.

1 reference

12 December 2020

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

12 December 2020

Biotherapeutic approaches to pancreatic cancer

1 reference

12 December 2020

Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway

1 reference

12 December 2020

Pancreatic stellate cells: partners in crime with pancreatic cancer cells

1 reference

12 December 2020

Neoadjuvant therapy for pancreatic cancer

1 reference

12 December 2020

Pancreatic cancer-associated stroma production

1 reference

12 December 2020

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

1 reference

12 December 2020

Human pancreatic cancer stem cells: implications for how we treat pancreatic cancer

1 reference

12 December 2020

Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies

1 reference

12 December 2020

Chemotherapy and tumor immunity: an unexpected collaboration

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

1 reference

12 December 2020

Tumor-stroma interactions in pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

1 reference

12 December 2020

Chronic inflammation and pathogenesis of GI and pancreatic cancers.

1 reference

12 December 2020

Establishment of three-dimensional cultures of human pancreatic duct epithelial cells

1 reference

12 December 2020

Inflammatory mechanisms contributing to pancreatic cancer development

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Identification of pancreatic cancer stem cells

1 reference

12 December 2020

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

1 reference

12 December 2020

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

1 reference

12 December 2020

Lately, it occurs to me what a long, strange trip it's been for the farnesyltransferase inhibitors

1 reference

12 December 2020

Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts

1 reference

12 December 2020

Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer

1 reference

12 December 2020

Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2009.21.9022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19858397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference